Skip to main content

Home›Research›Compare›Cerebrolysin vs Vasopressin

Peptide Comparison

Cerebrolysin vs Vasopressin

Both are Neuro & Cognitive peptides.

Cerebrolysin

FPF 1070

CognitiveInvestigationalResearch Only

Half-life: Varies by component

40 providers listed

Full Cerebrolysin profile →
vs

Vasopressin

ADH

CognitiveFDA ApprovedPrescription

Half-life: 10-20 minutes

4 providers listed

Full Vasopressin profile →
Bottom line

Vasopressin is FDA-approved, while Cerebrolysin is investigational — the clearest structural difference between them.

Quick Verdict

Cerebrolysin

Half-life

Varies by component

Vasopressin

Half-life

10-20 minutes

Which One Should You Choose?
Your goalBetter option
Further along in FDA reviewVasopressin
More provider options (40 vs 4)Cerebrolysin

Research summary only — not medical advice. Consult a qualified provider before making any decisions.

Side-by-Side Comparison
Cerebrolysin
Vasopressin
Mechanism Family
Neuro & Cognitive
Neuro & Cognitive
Half-life
Varies by component
10-20 minutes
FDA Status
investigational
approved
Admin Routes
intravenous, intramuscular
intranasal, subcutaneous, intravenous
Availability
Research Only
Prescription
Providers
40 listed
4 listed
FDA Update
—
Apr 2014
Avail. Notes
Neuropeptide mixture approved in EU/Asia but NOT FDA-approved. Phase 2/3 US trials for Alzheimer's disease and stroke with active IND. No NDA filed. Research use in US.
FDA-approved vasopressin injection. Brand: Vasostrict (NDA 204485, Apr 2014). Indicated for vasodilatory shock. As an FDA-approved drug with a USP monograph, it is compounded via the approved-drug / monograph route rather than the 503A bulk-substances list. Prescription only.
Research Evidence

Cerebrolysin

Meta-analysis · 5 key studies · most recent 2026

Vasopressin

Meta-analysis · 7 key studies · most recent 2026
Research Citations

About Cerebrolysin

Standardized mixture of neuropeptides derived from porcine brain proteins; mimics endogenous neurotrophic factors (BDNF, NGF, CNTF); promotes neurogenesis and synaptic plasticity

Research Areas
neuroprotectionneuroplasticitymemory improvementcognitive recovery

About Vasopressin

Neuropeptide binding V1aR (social behavior/memory, vasoconstriction), V1bR (ACTH/stress), V2R (antidiuretic); enhances hippocampal memory consolidation and social recognition

Research Areas
memory consolidationsocial memoryfluid retentionvasoconstriction
Safety Profile

Information below reflects published research data only — not medical advice. Consult a qualified provider before use.

Cerebrolysin

Reported (Unverified — Pending Clinical Review)
epilepsyrenal failureporcine protein allergy

No established clinical contraindications

Vasopressin

Reported (Unverified — Pending Clinical Review)
hypertensioncoronary artery diseasehyponatremia riskheart failure

No established clinical contraindications

Suggested Monitoring

Under clinical review

Being verified by our medical team before we display monitoring guidance for this peptide.

Price (per mg)

Cerebrolysin

$0.83/mg

$0.83 – $1.18 range

9 vendors

Vasopressin

Not enough vendor pricing yet.

Find Providers

Where to source these peptides

PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.

More Neuro & Cognitive Comparisons

Browse all peptides →

Educational research tools — not medical advice.

Cite this page

Data last updated October 26, 2026

Free to reference and republish with attribution to PeptideBase. Choose a format:

PeptideBase. (2026). Cerebrolysin vs Vasopressin — Per-mg Price Comparison. Retrieved October 27, 2026, from https://peptidebase.io/peptides/compare/cerebrolysin/vasopressin

Free newsletter

The Peptide Research Digest

Weekly analysis on providers, sourcing and compounds — from the team behind PeptideBase.

No spam. Unsubscribe anytime. Privacy policy.